Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call
24 Aprile 2024 - 10:05PM
Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it
will report first quarter financial results and provide a corporate
update on May 1, 2024. The company will also host a conference call
that day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).
Conference Call Information
Participants must register in advance of the conference call by
clicking here. Upon registering, each participant will receive a
dial-in number, and a unique access PIN. Each access PIN will
accommodate one caller.
Additionally, a listen-only webcast will be available by
clicking here.
A replay of the call will be available on the
Investors / Events tab of www.corcept.com.
About Corcept Therapeutics
For over 25 years, Corcept’s focus on cortisol
modulation and its potential to treat patients across a wide
variety of serious disorders has led to the discovery of more than
1,000 proprietary selective cortisol modulators. Corcept’s advanced
clinical trials are being conducted in patients with
hypercortisolism, solid tumors, amyotrophic lateral sclerosis (ALS)
and non-alcoholic steatohepatitis (NASH). In February 2012, the
company introduced Korlym®, the first medication approved by the
U.S. Food and Drug Administration for the treatment of patients
with Cushing’s syndrome. Corcept is headquartered in Menlo Park,
California. For more information, visit www.corcept.com.
CONTACT:Investor
inquiries:ir@corcept.comMedia inquiries:communications@corcept.com
www.corcept.com
Grafico Azioni Corcept Therapeutics (NASDAQ:CORT)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Corcept Therapeutics (NASDAQ:CORT)
Storico
Da Giu 2023 a Giu 2024